RNA knockout [34] and compound inhibition of BRAF [35]–[37] causes cell cycle arrest and death of mutant BRAF tumor cells, mitigating the clinical use of BRAF inhibitors for treatment of activated BRAF-driven cancers. The gene discussed is BRAF; the disease is neoplasm.